icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C: Integrated analysis of 12 clinical practice cohorts
 
 
  Reported by Jules Levin
European Association for the Study of the Liver's 54th Annual International Liver Congress, 10-14 April 2019, Vienna, Austria
 
Dr. Alessandra Mangia
 
IRCCS-Ospedale Casa Sollievo Della Sofferenza
San Giovanni Rotondo, Italy
Dr. Scott Milligan; Prof. Mandana Khalili; Prof. Stefano Fagiuoli; Dr. Stephen D Shafran; Prof Fabrice Carrat; Prof. Denis Ouzan; Prof. George Papatheodoridis; Dr. Alnoor Ramji; Dr. Sergio M Borgia; Prof. Heiner Wedemeyer; Ruggero Losappio; Francisco Pérez; Ms. Nicole Wick; Dr. Dawn Fishbein; Prof. Pietro Lampertico; Dr.Karen Doucette; Dr. Michael Mertens; Dr. Kim Vanstraelen; Dr. Juan Turnes

0411191

0411192

0411193

0411194

0411195

0411196

0411197

0411198